Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Kittelmann

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biotechnology and Bioengineering|May 28, 2010
Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesisKirsten Schroer, Matthias Kittelmann, Stephan Lütz
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2018
Gas-Phase Rearrangement of the <i>O</i>-Glucuronide of Vildagliptin Forms Product-Ion Fragments Suggesting Wrongly an <i>N</i>-GlucuronideAndreas Fredenhagen, Jürgen Kühnöl, Matthias Kittelmann, et al.
Chimia|January 5, 2011
Swiss Industrial Biocatalysis Consortium (SIBC)Beat Wirz, Matthias Kittelmann, Hans-Peter Meyer, et al.
Chimia|June 3, 2020
The Development of Biocatalysis as a Tool for Drug DiscoveryJenny Schwarz, Katrin Rosenthal, Radka Snajdrova, et al.
Chemical Communications (Cambridge, England)|May 12, 2012
Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scaleSteven P Hanlon, Andrea Camattari, Sandra Abad, et al.
Journal of Biotechnology|March 30, 2016
Human xanthine oxidase recombinant in E. coli: A whole cell catalyst for preparative drug metabolite synthesisMárcia Ferreira Antunes, Fabian Kurt Eggimann, Matthias Kittelmann, et al.
Biopharmaceutics & Drug Disposition|March 20, 2020
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonistRenata Murgasova, Ester Tor Carreras, Martina Suetterlin-Hachmann, et al.
Microbial Cell Factories|June 12, 2015
Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesisMartina Geier, Thorsten Bachler, Steven P Hanlon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589)Andreas Fredenhagen, Matthias Kittelmann, Lukas Oberer, et al.
Biotechnology and Bioengineering|June 27, 2018
A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450sAnne Worsch, Fabian Kurt Eggimann, Marco Girhard, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biotechnology and Bioengineering|May 28, 2010
Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesisKirsten Schroer, Matthias Kittelmann, Stephan Lütz
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2018
Gas-Phase Rearrangement of the <i>O</i>-Glucuronide of Vildagliptin Forms Product-Ion Fragments Suggesting Wrongly an <i>N</i>-GlucuronideAndreas Fredenhagen, Jürgen Kühnöl, Matthias Kittelmann, et al.
Chimia|January 5, 2011
Swiss Industrial Biocatalysis Consortium (SIBC)Beat Wirz, Matthias Kittelmann, Hans-Peter Meyer, et al.
Chimia|June 3, 2020
The Development of Biocatalysis as a Tool for Drug DiscoveryJenny Schwarz, Katrin Rosenthal, Radka Snajdrova, et al.
Chemical Communications (Cambridge, England)|May 12, 2012
Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scaleSteven P Hanlon, Andrea Camattari, Sandra Abad, et al.
Journal of Biotechnology|March 30, 2016
Human xanthine oxidase recombinant in E. coli: A whole cell catalyst for preparative drug metabolite synthesisMárcia Ferreira Antunes, Fabian Kurt Eggimann, Matthias Kittelmann, et al.
Biopharmaceutics & Drug Disposition|March 20, 2020
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonistRenata Murgasova, Ester Tor Carreras, Martina Suetterlin-Hachmann, et al.
Microbial Cell Factories|June 12, 2015
Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesisMartina Geier, Thorsten Bachler, Steven P Hanlon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589)Andreas Fredenhagen, Matthias Kittelmann, Lukas Oberer, et al.
Biotechnology and Bioengineering|June 27, 2018
A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450sAnne Worsch, Fabian Kurt Eggimann, Marco Girhard, et al.
Pageof 2